Skip to content

Optimization of Sampling and Processing of Samples for Molecular Microbial Research on Ocular Surface Samples

Optimization of Sampling for Molecular Microbial Research on Ocular Surface Samples and Building a Framework for Comparing Current Sequencing Results Using Different Extraction Protocols.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04193774
Acronym
EPSO
Enrollment
24
Registered
2019-12-10
Start date
2019-08-19
Completion date
2021-12-31
Last updated
2022-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microbiota, Ocular Surface

Keywords

Ocular surface microbiome, Anesthesia, Extraction protocol

Brief summary

The use of anesthetics and the processing of the retrieved samples are major confounding factors that influence the results of microbiome research.

Detailed description

The use of anesthetics is subject of discussion in ocular surface microbiome research. One publication showed a significant lower alpha diversity when using an anesthetic. However, the diluting effect of the anesthetic drop itself was not accounted for. On the other hand, using anesthetics will enable patients to tolerate sampling better and this might allow better sampling. To analyze the effect of anesthetic drops on the composition of the ocular surface microbiome, we sampled volunteers undergoing general anesthesia. By using artificial tears as a control, we aimed at accounting for the diluting effect of the anesthetic. By using volunteers under general anesthesia, we wanted to assure similar pressure with or without topical anesthesia since the executor was not influenced by the patient's reaction. Furthermore, the effect of different extraction protocols on sequencing results will be assessed by sampling different volunteers in both eyes on non consecutive days.

Interventions

DIAGNOSTIC_TESTConjunctival swab

Swab of the conjunctival fornices of both eyes

DRUGOxybuprocaine Hydrochloride 0.4% Eye Drops

One drop of topical anesthesia in one eye

DRUGartificial tears

One drop of artificial tears in the other eye

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Caregiver, Investigator)

Masking description

The nurse application the drops receives a closed envelope wherein the information about which eye receives what type of drop is included. The executor is blinded.

Intervention model description

When the patient is under general anesthesia for another reason, he or she receives a drop of artificial tears in one eye and a drop of anesthetic in the other eye in a randomized way.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Willing to undergo sampling of the conjunctiva * Fluent in written and verbal Dutch * Capable of giving informed consent

Exclusion criteria

* Allergy to oxybuprocaine * Medication usage in one eye only

Design outcomes

Primary

MeasureTime frameDescription
Difference in richness of the microbial flora measured as operational taxonomic units5 minutes per sampling sessionThe difference in richness and evenness of distribution of the microbial flora of samples retrieved after a drop of topical anesthesia versus samples retrieved after a drop of artificial tears.
Difference in evenness of distribution of the microbial flora measured as operational taxonomic units5 minutes per sampling sessionThe effect of the different microbial DNA extraction protocols on the richness and evenness of distribution of the microbial flora of the ocular surface will be compared.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026